Search Results 1781-1790 of 21373 for anti-TNF drugs

1. Gastric acid suppression medications increase risk for recurrence of Clostridium difficile infection - Mayo Clinic News Network

   C-diff is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. The study is published in JAMA Internal ...

2. Hodgkin lymphoma (Hodgkin disease) - Care at Mayo Clinic

   Mayo Clinic radiation oncologists plan and deliver radiation therapy safely using advances such as volumetric modulated arc therapy and proton therapy. These ...

3. A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus - Mayo Clinic

   drug. 2. Previous anti-cancer hormonal treatment or anti-cancer immunotherapy within 2 weeks of the first administration of trial drug. 3. Previous treatment ...

4. Teriparatide (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Formoterol (Inhalation Route) Description and Brand Names - Mayo Clinic

   Formoterol is used together with other medicines (eg, inhaled corticosteroids) to treat asthma and prevent bronchospasm in patients with asthma. When used ...

6. Glofitamab-Gxbm (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Columvi. Descriptions. Glofitamab-gxbm injection is used to ...

7. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Has any unresolved toxicity grade > 1 from previous anti-cancer therapy. Subject use of immunosuppressive medication within 14 days before the Cycle 1 Day 1:.

8. Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer - Mayo Clinic

   Participation eligibility · Cisplatin ineligibility is defined as meeting one of the following criteria: · Anti PD-1/PD-L1 therapy administered as part of ...

9. Thalidomide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

10. A Study to Evaluate the Use of Adipose-derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis - Mayo Clinic

    Patients receiving treatment with hematopoietic growth factors or anti-vasculogenesis or anti-angiogenesis treatment (e.g., anti-VEGF). Patients requiring ...